Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Free Report) was the recipient of a large increase in short interest in December. As of December 15th, there was short interest totalling 606,200 shares, an increase of 427.1% from the November 30th total of 115,000 shares. Currently, 1.2% of the company’s shares are sold short. Based on an average trading volume of 712,600 shares, the short-interest ratio is currently 0.9 days.
Eterna Therapeutics Price Performance
Shares of Eterna Therapeutics stock traded down $0.03 on Friday, hitting $0.25. 314,135 shares of the company’s stock traded hands, compared to its average volume of 196,055. The company has a market capitalization of $1.37 million, a price-to-earnings ratio of -0.03 and a beta of 4.18. The company has a fifty day moving average of $0.65 and a two-hundred day moving average of $1.30. Eterna Therapeutics has a one year low of $0.22 and a one year high of $2.63.
Eterna Therapeutics Company Profile
Read More
- Five stocks we like better than Eterna Therapeutics
- Short Selling: How to Short a Stock
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- How to Most Effectively Use the MarketBeat Earnings Screener
- How AI Implementation Could Help MongoDB Roar Back in 2025
- Health Care Stocks Explained: Why You Might Want to Invest
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for Eterna Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eterna Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
